e2f3 primary antibodies (Proteintech)
Structured Review

E2f3 Primary Antibodies, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 22 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+e2f3+primary+antibody/E2F3+Antibody/pmc12801454-60-8-11
Average 93 stars, based on 22 article reviews
Images
1) Product Images from "Circ_0001741 regulates proliferation and invasion in ESCC via the miR-194-5p/E2F3 axis"
Article Title: Circ_0001741 regulates proliferation and invasion in ESCC via the miR-194-5p/E2F3 axis
Journal: World Journal of Surgical Oncology
doi: 10.1186/s12957-025-04124-2
Figure Legend Snippet: E2F3 is a miR-194-5p target gene in TE2 and KYSE150 cells A Predicted partially complementary binding sequence between E2F3 mRNA and miR-194-5p B Dual-luciferase reporter assays confirming miR-194-5p binding to the E2F3 3’UTR. C Pull-down assay was used to confirm the interaction of E2F3 and miR-194-5p D Western blot analysis of E2F3 protein levels in TE2 cells after miR-194-5p overexpression. * P < 0.05
Techniques Used: Binding Assay, Sequencing, Luciferase, Pull Down Assay, Western Blot, Over Expression
Figure Legend Snippet: E2F3 overexpression reverses the effects of circ_0001741 knockdown A E2F3 overexpression partially rescues the anti-invasive effects of si-circ_0001741 or miR-194-5p in TE2 and KYSE150 cells B E2F3 overexpression partially restores proliferation suppressed by si-circ_0001741 or miR-194-5p. * P < 0.05
Techniques Used: Over Expression, Knockdown
Related Articles
Blocking Assay:Article Title: Identification of a novel prognostic signature composed of 3 cuproptosis-related transcription factors in colon adenocarcinoma. Article Snippet: Background Since the mechanism of cuproptosis was recently revealed, many molecules related to this pathway have been widely concerned and exploited to have prognostic potential.. However, it is still unknown whether the transcription factors related to cuproptosis could be competent as tumor biomarkers of colon adenocarcinoma (COAD).. Objective To analyze the prognostic potential of cuproptosis-related transcription factors in COAD, and validate the representative molecule. |
